CLINICAL_TRIALS
trial_result
· 2020-02-28
Clinical Trial Update: A Study of MLN9708 in Japanese Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) [Phase 1]
Summary
Phase 1 clinical trial of MLN9708 in Japanese participants with relapsed/refractory multiple myeloma was terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Relapsed and/or Refractory Multiple Myeloma | Phase 1 | Status: TERMINATED | Results posted: 2020-02-28